BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr | ₹5.00 Cr |
What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹10 Cr |
Mar2022 | ₹6.17 Cr |
Mar2021 | ₹2.00 Cr |
Mar2020 | ₹5.00 Cr |
How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | 67.43 | |
Mar2023 | ₹10 Cr | 69.85 | |
Mar2022 | ₹6.17 Cr | 208.45 | |
Mar2021 | ₹2.00 Cr | -60.00 | |
Mar2020 | ₹5.00 Cr | - |
Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹176.6 Cr | -2.7% | -0.5% | -27.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,588.0 Cr | -7.3% | 1.1% | 15.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,711.0 Cr | -3.5% | 12.9% | 53.4% | Stock Analytics | |
CIPLA | ₹122,115.0 Cr | 0.1% | 9.2% | 6.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,589.0 Cr | -1% | 0.2% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,746.6 Cr | 3.1% | 9.8% | -7.6% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -2.7% |
-0.5% |
-27.2% |
SENSEX | 2% |
9.4% |
11.6% |
You may also like the below Video Courses